This brand name is authorized in Estonia, Spain, Lithuania, Netherlands, South Africa
The drug SORBISTERIT contains one active pharmaceutical ingredient (API):
|
1
Polystyrene sulfonate
UNII 199995D30M - CALCIUM PHENOLSULFONATE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V03AE01 | Polystyrene sulfonate | V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1271775, 1501928, 1683693 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 69234 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1004943, 1057159, 1077079, 1081255, 1084661 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 13485512 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 130664 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 43/18.3/0701 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
